Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA) employs 15,300 people and is active in three main fields: energy, information and health technologies, defence and national security. The Fundamental Research Directorate is in charge of health research and related technologies and includes the “Institut de Biologie François Jacob”, hosting the “Infectious Disease Models for Innovative Therapies” (IDMIT) Department headed by Dr. Roger Le Grand. IDMIT’s mission is to provide the academic and industrial scientific community with state-of-the-art expertise, facilities and technologies for pre-clinical studies, particularly through the development of non-human primate models of human infectious diseases and immune disorders.
Main roles in project
CEA will evaluate the immunogenicity and efficacy of the CRUZIVAX candidate vaccine in non-human primates, using immune monitoring as well as cutting-edge mass cytometry (CyTof) and in vivo imaging technologies.
This project has received funding from the European Union’s Horizon 2020 research and innovationprogramme under grant agreement No 815418.